GPS Wealth Strategies Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.1K | Hold |
515
| – | – | ﹤0.01% | 807 |
|
|
2025
Q1 | $17.5K | Buy |
515
+25
| +5% | +$851 | ﹤0.01% | 857 |
|
|
2024
Q4 | $19.3K | Sell |
490
-127
| -21% | -$5K | ﹤0.01% | 804 |
|
|
2024
Q3 | $29K | Buy |
617
+2
| +0.3% | +$94 | ﹤0.01% | 711 |
|
|
2024
Q2 | $33.2K | Buy |
615
+307
| +100% | +$16.6K | 0.01% | 642 |
|
|
2024
Q1 | $21K | Sell |
308
-15
| -5% | -$1.02K | ﹤0.01% | 712 |
|
|
2023
Q4 | $20.2K | Buy |
323
+100
| +45% | +$6.26K | ﹤0.01% | 695 |
|
|
2023
Q3 | $10.1K | Buy |
223
+15
| +7% | +$681 | ﹤0.01% | 836 |
|
|
2023
Q2 | $11.7K | Buy |
208
+183
| +732% | +$10.3K | ﹤0.01% | 821 |
|
|
2023
Q1 | $1.13K | Buy |
+25
| New | +$1.13K | ﹤0.01% | 1155 |
|
|
2022
Q4 | – | Sell |
-25
| Closed | -$2K | – | 323 |
|
|
2022
Q3 | $2K | Hold |
25
| – | – | ﹤0.01% | 1028 |
|
|
2022
Q2 | $2K | Hold |
25
| – | – | ﹤0.01% | 1010 |
|
|
2022
Q1 | $2K | Hold |
25
| – | – | ﹤0.01% | 959 |
|
|
2021
Q4 | $2K | Hold |
25
| – | – | ﹤0.01% | 975 |
|
|
2021
Q3 | $3K | Buy |
+25
| New | +$3K | ﹤0.01% | 899 |
|